Klotho Neurosciences, Inc. (KLTOW)
KLTOW Stock Price Chart
Explore Klotho Neurosciences, Inc. interactive price chart. Choose custom timeframes to analyze KLTOW price movements and trends.
KLTOW Company Profile
Discover essential business fundamentals and corporate details for Klotho Neurosciences, Inc. (KLTOW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
3.00
Website
https://klothoneuro.comCEO
Joseph Sinkule
Description
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
KLTOW Financial Timeline
Browse a chronological timeline of Klotho Neurosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
KLTOW Stock Performance
Access detailed KLTOW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.